Breaking News

Kemwell Contracted by Mercury

December 7, 2012

Will manufacture tablets at Uppsala

Kemwell AB has signed an agreement with Mercury Pharma Group Ltd. for the manufacture of pharmaceuticals at its new production facility in Uppsala. The agreement covers the manufacture of tablets and release and distribution of products to Great Britain and Ireland.
“This agreement shows that we are indeed competitive in Sweden in production. Our new modern facility gives great opportunities for pharmaceutical manufacture in collaboration with both new and existing customers,” said Kemwell’s chief executive officer, Agneta Bergvall.
Kemwell is a CMO with production facilities in both India and Sweden. The company was established through the acquisition of a facility from Pfizer, with manufacturing capabilities for tablets, suppositories and capsules.

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important